Chemoprevention has been widely explored as a promising strategy for controlling the incidence of lung cancer, the leading cause of cancer-related death. To maximize the benefit of lung cancer chemoprevention, it is important to identify individuals at high risk for the disease. The genetic background has been shown to play an important role in one's risk of developing lung cancer. We report here the identification of a polymorphic tandem repeats minisatellite (termed MNS16A) in the downstream region of the human telomerase gene. This minisatellite is located upstream of an antisense transcript from the human telomerase gene locus and was demonstrated to have promoter activity. The promoter activity was significantly lower in the construct containing the shorter repeats, suggesting that the MNS16A variant may have a relevance of functionality. To explore the role of this novel polymorphism in lung cancer, we conducted a pilot hospital-based case-control study by identifying the MNS16A genotype with genomic DNA from 53 lung cancer patients and 72 cancer-free controls. We found four different alleles and classified them as shorter (S) or longer (L) on the functional basis of the length of the repeats in the controls. The MNS16A genotype distributions of the SS, SL, and LL genotypes were 11, 32, and 57%, respectively, in the cases, and 14, 40, and 46%, respectively, in the controls. Compared with the SS þ SL genotype, the LL genotype was associated with greater than twofold increased risk of lung cancer (odds ratio ¼ 2.18; 95% confidence interval ¼ 0.92, 5.20) after adjustment for age, sex, ethnicity, and smoking status, suggesting a potential role of MNS16A in lung cancer susceptibility. Larger studies are needed to verify our findings.
Introduction
Lung cancer is the leading cause of cancer-related death for both men and women in the United States (ACS, 2003) . Despite improvements in diagnosis and therapy, the overall survival of patients with lung cancer remains dismal (Parkin et al., 1999) . One of the promising approaches to the prevention of lung cancer is the use of chemopreventive agents. Since preventive treatment may be long term and because the agents used may have certain side effects, it is important to limit chemopreventive treatment to those individuals at high risk of developing lung cancer.
Tobacco smoking is the most important etiologic factor in lung cancer development. However, less than 15% of heavy smokers are expected to develop lung cancer in their lifetime, suggesting the presence of other factors important for the development of the disease. An individual's genetic variation has been shown to play an important role in one's susceptibility to lung cancer. For instance, polymorphism in genes involving detoxification enzymes (Bouchardy et al., 2001) and DNA repairs (Goode et al., 2002) has been shown to play a role in susceptibility to lung cancer. In a recent study, we found that a C/T polymorphism in the promoter region of a novel cytosine DNA-methyltransferase 3B6 is associated with the risk of lung cancer development (Shen et al., 2002) , suggesting that the role of polymorphisms in many other genes involved in carcinogenesis of lung cancer needs to be explored.
Human telomerase (hTERT) gene is located to chromosome 5p15.33 and encodes a ribonucleoprotein enzyme that extends chromosome ends that have been shortened during successive cycles of cell division (Greider and Blackburn, 1985) . Telomerase is composed of an RNA component, a catalytic protein subunit, and other telomerase-associated proteins whose functions remain to be established (Feng et al., 1995) . Telomerase is expressed in the vast majority of human malignant cell lines and tumors, but not in the corresponding benign tissues (Dhaene et al., 2000) . Studies of human tumors and human tumor cell lines have shown that telomerase activation plays a critical role in tumorigenesis, including lung tumorigenesis, by sustaining cellular immortality (Kim et al., 1994; Hiyama et al., 1995; Albanell et al., 1997) . Overexpression of the RNA component of human telomerase has been observed at a very early stage in the pathogenesis of nonsmall-cell lung cancer (NSCLC) (Yashima et al., 1997) . However, such expression is not limited to the cells that harbor telomerase activity. By contrast, expression of hTERT is more closely associated with telomerase activity (Meyerson et al., 1997; Nakamura et al., 1997) . In our previous studies, we demonstrated that hTERT expression occurred early in lung carcinogenesis and was associated with a poorer clinical outcome in patients with early-stage NSCLC (Soria et al., 2001; Wang et al., 2002) . Interestingly, during these studies, we noticed the presence of an antisense transcript signal detected by in situ hybridization in cells expressing hTERT, suggesting the existence of an antisense hTERT mRNA, which might play a role in regulation of hTERT expression. To identify genetic variation in hTERT that may participate in the regulation of hTERT expression, we sequenced this locus and found a novel polymorphic tandem repeats minisatellite, termed MNS16A, in the downstream region of the hTERT gene locus. The region containing MNS16A was demonstrated to have a promoter activity that was influenced by the length of the MNS16A tandem repeats, suggesting a potential role of this minisatellite in regulating expression of the antisense hTERT mRNA. In this study, we also provided preliminary evidence of a possible association between MNS16A variable number of tandem repeats (VNTR) and risk of lung cancer.
Results
hTERT clusters with minisatellites and microsatellites, including a unique functional tandem repeats minisatellite in the downstream region of the gene. The hTERT gene is located at chromosome 5p15.33 and has 16 exons (Wick et al., 1999; Bryce et al., 2000) . Analysing the genomic sequence published in GenBank (Accession numbers AY007685), we found that the gene contains many minisatellites and microsatellites, which divide the gene into four exon clusters (Figure 1 ). All the seven reported major conserved motifs of the telomerase subunit (Xiong and Eickbush, 1990) are located in the second and third clusters. The fourth cluster contains exons 13-16; however, it is further divided by minisatellites or microsatellites (Figure 1) . Interestingly, during our earlier studies in which we used in situ hybridization to evaluate hTERT mRNA expression as a biomarker in lung tumorigenesis and progression (Soria et al., 2001; Wang et al., 2002) , we found that with single-strand sense RNA riboprobes specific to the antisense mRNA sequences of various hTERT exons, a strong positive signal could be detected in cells with active telomerase but not in cells of telomerase-negative alternativelengthening-of-telomeres cell line KB319 (Figure 2 ). This finding suggested the presence of hTERT antisense sequences. Further study showed that the antisense RNA transcript was initiated at the downstream of hTERT gene and had two major starting points at nt 22156 and nt 22163 (GenBank AF128894), respectively (unpublished data).
In the study reported here, we found a unique tandem repeats sequence, which we termed MNS16A, in the putative promoter region of this antisense RNA transcript. This repeats sequence was a typical minisatellite with two different VNTR alleles in the cancer cell lines tested (Figure 3a ). These two VNTR alleles were named as VNTR-302 and VNTR-243 on the basis of the PCR fragment size. The core sequence of MNS16A is a 23 bp tandem repeat of TCC TCT TAT CTC CCA GTC TCA TC or a 26 bp sequence with a CAT insertion. The VNTR-302 contains two 23 bp repeats and three 26 bp repeats, while the VNTR-243 contains one 23 bp repeat and two 26 bp repeats (Figure 3b) . Interestingly, analysis with Transcription Element Search Software (TESS; URL: http://www.cbil.upenn.edu/tess) showed that the 26 bp tandem repeat with a CAT trinucleotide is a binding site for the transcription factor GATA-1, prompting us to investigate whether this tandem repeat plays a role in promoter activity.
The promoter activity of MNS16A depends on the length of the VNTR sequence size. Luciferase assay was performed to characterize the potential promoter activity of MNS16A ( Figure 3c ). We found that promoter activity was twice as strong with the pGL3-570(S) forward construct as it was with the pGL3-570(R) reverse construct, indicating the presence of a promoter in this region containing the MNS16A sequence. Promoter activity was much weaker with the pGL3-660(S) construct, which contains the VNTR-302, than with the pGL3-570(S) construct, which contains the VNTR-243. This suggested that promoter activity depended on the length of MNS16A VNTR and MNS16A functioned as a repressor for this promoter. This observation was further confirmed by using two additional constructs, pGL3-243 and pGL3-302, that contained only the tandem repeats VNTR-243 or VNTR-302 (data not shown). The structure of the core promoter that initiated the antisense transcript is illustrated in Figure 3d . It was interesting that the NSCLC cell line H460, which has a VNTR-302/243 genotype, showed a stronger antisense hTERT RNA MNS16A polymorphic allele associated with lung cancer susceptibility. In addition to MNS16A VNTR-243 and VNTR-302 observed in the cancer cell lines (Figure 3a ), two other rare alleles, VNTR-272 and VNTR-333, were also identified (data not shown). We classified the alleles VNTR-243 and VNTR-272 as short repeats (S allele), while VNTR-302 and VNTR-333 as long repeats (L allele). To explore the role of this novel polymorphism in lung cancer, we conducted a pilot hospital-based case-control study. The MNS16A genotype was determined with the genomic DNA from the tumor and blood samples of 53 lung cancer patients who were diagnosed with NSCLC and underwent surgery, and blood samples of 72 cancer-free controls who enrolled into our various clinical chemoprevention trials (n ¼ 57) and who were seen at MD Anderson without clinical evidence of lung cancer (N ¼ 15). For smoking status, 'ever smokers' were defined as those who smoked more than 100 cigarettes in their lifetime, of which they were 'former smokers' if they quit more than a year or 'current smokers' otherwise. Although there was no gender difference between the cases and controls, the cases (mean7s.d., 65.579.6 years) were younger than the controls (54.9710.3 years), and there were more Caucasians and current smokers in the cases (41.5 and 96.2%, respectively) than in the controls (90.3 and 15.3%, respectively) ( Table 1 ). These differences were adjusted for in the multivariate logistic regression analysis. We found four different alleles and classified them as shorter (S) or longer (L) on the functional basis of the length of the repeats in the controls. The MNS16A genotype distributions of the SS, SL, and LL genotypes were 11, 32, and 57%, respectively, in the cases, and 14, 40, and 46%, respectively, in the controls, which was not statistically different (Table 2) . Compared with the SS þ SL genotype, the LL genotype was associated with greater than twofold increased risk of lung cancer (odds ratio ¼ 2.18; 95% confidence interval ¼ 0.92, 5.20), after adjustment for age, sex, ethnicity, and smoking status (Table 2) . These data suggest a potential role of MNS16A in lung cancer susceptibility. However, this pilot study was small and less than optimal; larger studies with a more rigorous study design and sufficient power are warranted to substantiate these findings.
Discussion
Minisatellite sequences are mutated at a high rate in germ cells but are relatively stable in somatic cells (Jeffreys et al., 1994) , creating non- et al., 1994) . Minisatellite mutations have also been found in various human tumors (Thein et al., 1987; Matsumura and Tarin, 1992) and experimental animal tumors induced by chemical carcinogens (Ledwith et al., 1990 (Ledwith et al., , 1995 . Studies have shown high rearrangement frequencies in different types of cancers for two atypical minisatellites, the AT-rich ApoB locus and the VNTR locus D1S7, which have an atypically short repeat unit and may be susceptible to polymerase slippage (HoffOlsen et al., 1995; Kaplanski et al., 1997) . Somatic mutations in the D1S7 locus have been found to be associated with microsatellite instability in human colorectal carcinomas (Kaplanski et al., 1997) . Minisatellite instability has also been demonstrated to exist in severe-combined-immunodeficiency fibroblasts, which have a mutation in the catalytic subunit of DNAdependent protein kinase, suggesting that this subunit may be involved in the stable maintenance of minisatellite sequences in the genome (Imai et al., 1997) .
Single nucleotide polymorphism within genes or potential functional components of genes has been shown to be associated with susceptibility to various diseases, including lung cancer (Wei et al., 2000; Spitz et al., 2001) . For instance, in our recent study on different genetic variants of DNA methyltransferase 3B, we found that a functional C/T polymorphism in the promoter region could contribute to the risk of lung cancer development (Shen et al., 2002) . However, the potential biological consequences of minisatellite polymorphism have not been well recognized. In the study reported here, we identified an antisense hTERT mRNA transcript and its promoter whose activity depended on the length of tandem repeats. To our knowledge, this is the first report of a novel controlling mechanism of gene regulation, which showed that a tandem repeat minisatellite functioned as a part of promoter. The strong presence of the antisense molecule in cancer cell KB319 lacking hTERT expression suggests that expression of the antisense molecule is independent of hTERT. Even if it was possible that the antisense hTERT RNA could act as an inhibitor of hTERT by reducing its transcription or blocking its translation (unpublished data), however, the natural biological function of this antisense mRNA remains unknown and needs further studies. Nevertheless, because activation of telomerase plays an important role in early lung carcinogenesis (Yashima et al., 1997) and is also associated with lung cancer progression , it is likely that the level of antisense mRNA may contribute to the development of lung cancer. Szutorisz et al. (2001) identified two polymorphic minisatellites located in intron 2 and intron 6 of human telomerase gene. The polymorphic minisatellite in intron 2 was found to contain binding sites for c-Myc that has been shown to upregulate hTERT transcription. However, there were only minor variations and one deletion seen in the 38 colon carcinomas analysed, which led the authors to conclude that the size rearrangements of the hTERT minisatellites are not required for telomerase expression in colon carcinomas (Szutorisz et al., 2001) . However, in a recent work, eight alleles of intron 6 VNTR and four alleles of intron 2 VNTR in hTERT gene locus were identified among 103 unrelated individuals, and in one patient with a kidney tumor, the VNTR in intron 6 was found to have undergone concomitant rearrangements, suggesting that chromosomal rearrangements of these VNTR may be associated with the activation of hTERT in cancer cells (Leem et al., 2002) . Consistent with the above reports, we also found rearrangement of the MNS16A VNTR in 11 primary lung tumors examined in our another study (data not shown). However, the association of the rearrangement with hTERT expression levels has not yet been determined because of the lack of reliable quantitative methods.
Our finding that patients with NSCLC have a higher frequency of the MNS16A LL genotype is important, because it supports the notion that the antisense hTERT mRNA has a biological function, which may be exerted through interference with hTERT levels. Our finding that minisatellite length influences promoter activity, together with the finding that minisatellite length was possibly related to lung cancer susceptibility, suggests a role of minisatellites in regulation of gene expression and contributes to diversity of human cell biology. Further studies with larger cohorts are necessary to validate our findings.
Materials and methods
Tissue, cell specimens, and study population H157, H226, H226Br, H460, H1299, and H1944 human NSCLC cells were purchased from American Type Culture Collection (Rockville, MD, USA). SK-MES and 17B squamous carcinoma of the head and neck were obtained from Dr Adi Gazdar (University of Texas Southwestern Medical Center, Dallas, TX, USA). The telomerase-negative alternative-lengthening-of-telomeres cell line KB319 was a gift from Drs John Murnane and Laure Sabatier, Radiation Oncology Research Laboratory, University of California, San Francisco, USA (Murnane et al., 1994) . Cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% heatinactivated fetal calf serum, 2 mm l-glutamine, 100 IU/ml penicillin, and 100 mg/ml streptomycin at 371C in the presence of 5% CO 2 .
Lung cancer tissues were obtained from 53 consecutive patients with NSCLC, who had undergone surgical resection with curative intent at MD Anderson Cancer Center between 1996 and 1998, and for whom archived tissues were available. These specimens were collected from the Department of Pathology and stored at À801C until use. All patients had consented to the use of their tissue specimens, and the The riboprobe used in this study was a 620 bp cDNA fragment RT-PCR-amplified from exons 10 to 15 by using the forward primer 5 0 -TCT TGT TGG TGA CAC CTC ACC-3 0 and the reverse primer 5 0 -TAG GTG ACA CGG TGT CGA GT-3 0 . The PCR fragment was then cloned into the pCR s II-TOPO vector (Invitrogen, Carlsbad, CA, USA). The plasmid was linearized with EcoRV, and the single-strand-specific riboprobe was transcribed in vitro with SP6 RNA polymerase (Promega, Madison, WI, USA) by using a DIG RNA Labeling Kit (Roche Diagnostics, Inc., Indianapolis, IN, USA). In situ hybridization was performed as previously described . Detection was performed using a DIG Nucleic Acid Detection Kit (Roche Diagnostics, Inc., Indianapolis, IN, USA) according to the manufacturer's directions. Anti-DIG alkaline phosphatase conjugated antibody was diluted 1 : 500. Nitro-blue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate were used as chromogens. Slides were then rinsed in TE buffer (10 mm Tris-HCl and 1 mm EDTA, pH 8) and mounted with Aqua-Mount medium (Fisher, Houston, TX, USA). Telomerase activity was measured by using the TRAP-eze Telomerase Detection Kit (Intergen, Purchase, NY, USA) according to the manufacturer's protocol.
Construction of the pGL3-570(S), pGL3-570(R), and pGL3-660(S) plasmids A 570 bp DNA fragment from the downstream region of hTERT gene (from base 22 141 to base 22 710, Accession number AF128894) was amplified from the cell line H460 by using the forward primer 5 0 -TTC TGA TGC TGT GAG GCA GG-3 0 and the reverse primer 5 0 -GAG AGA TGA GAC TGG GAG ATG-3 0 , and inserted into pGL3-basic vector (Promega). The plasmids with forward and reverse directions identical with the direction of hTERT genomic sequence in GenBank, were constructed and named as pGL3-570(S) and pGL3-570(R), respectively. The PCR reaction was performed in a 12.5-ml volume containing about 50 ng of genomic DNA, 7% dimethyl sulfoxide, 1.5 mm dNTPs, 6.7 mm MgCl 2 , 16.6 mm (NH 4 ) 2 SO 4 , 67mm Tris, 10 mm b-mercaptoethanol, 6.7 mm EDTA, 0.5 mm forward, 0.5 mm reverse primer, and 0.625 U of HotStar Taq DNA Polymerase (Qiagen, Inc., Chatsworth, CA, USA). Amplification was carried out with an initial denaturing step at 951C for 15 min, followed by 40 cycles of 951C for 30 s, 601C for 1 min, and 721C for 1 min in a thermal cycler (Hybaid; PCR Express, Middlesex, UK) with a last extension step of 721C for 10 min. The sequences of plasmids were confirmed by using an AmpliCycle sequencing kit according to the manufacturer's instructions (Applied Biosystems, Foster City, CA, USA). A 660 bp DNA fragment was also amplified using the same set of primers (containing additional repeats sequence) to construct the plasmid pGL3-660(S).
Construction of pGL3-302(S), pGL3-302(R) and pGL3-243(S), pGL3-243(R) plasmids Two smaller DNA fragments containing a 243 or 302 bp tandem repeat sequence (MNS16A) within the 570 or 660 bp fragment described above were amplified by using the forward primer S3-H 5 0 -AAA GCT TCT TCT GAT CTC TGA AGG G-3 0 and the reverse primer E17AS4-H 5 0 -AAA GCT TGC CTG AGG AAG GAC GTA-3 0 . These two fragments were also inserted into pGL3-basic vector. The plasmids with forward and reverse directions identical with the direction of hTERT genomic sequence in GenBank were constructed and named pGL3-302(S) and pGL3-302(R), respectively, and pGL3-243(S) and pGL3-243(R), respectively.
Transient transfection and luciferase assay
The plasmids were transfected into lung cancer cell line H1299 using Lipofect.AMINE reagent (GIBCO BRL, Grand Island, NY, USA) according to the manufacturer's protocol. Briefly, 5 Â 10 4 cells were spread into 24-well plates and incubated overnight. Then, 250 ng of plasmids and 50 ng of pCMVsportbeta gal (GIBCO BRL, Grand Island, NY, USA), which was used as the internal control to monitor the transfection efficiency, were added. After 6 h, the medium was replaced with a medium containing 10% fetal calf serum and 36 h later, the cells were harvested with cell lysis buffer. In each experiment, transfection was performed in triplicate and luciferase activity was measured by using a Luciferase Assay System (Promega Co., Madison, WI, USA) with a luminometer. b-galactosidase activity was measured with Betagalactosidases Enzyme Assay System with a report lysis buffer (Promega) following the manufacturer's instructions. The values of luciferase activities were normalized against those of b-galactosidase expressed by plasmid pCMVsport-b gal.
Genotyping of MNS16A
For genotyping of MNS16A, genomic DNA was extracted from leukocytes of surgically resected lung tissues. Briefly, the tissue was digested in 200 ml of 50 mm Tris-HCl (pH 8.0) containing 1% sodium dodecyl sulfate and proteinase K, and incubated at 421C for 24 h. DNA was purified using phenolchloroform extraction followed by ethanol precipitation. 'Hot-PCR' was used to determine the MNS16A genotype by using the forward primer 5 0 -AGG ATT CTG ATC TCT GAA GGG TG-3 0 , located at nt 22591, and the reverse primer 5 0 -TCT GCC TGA GGA AGG ACG TAT G-3 0 , located at nt 22871. Briefly, the reverse primer was endlabeled with g-32 P-ATP by using T4 polynucleotide kinase. The PCR reaction was performed in a 12.5-ml volume with an additional 0.02 mm of hot primer under the condition same as that mentioned above. Omission of DNA was used as a negative control. The PCR products were mixed with loading buffer, separated by electrophoresis on a 6% urea/formamide-denaturing polyacrylamide gel, and exposed to X-ray film.
Three different MNS16A genotypes, that is, LL-genotype (homozygotes), SS-genotype (homozygotes), and SL-genotype (heterozygotes), were defined on the basis of the functional structure of this tandem repeat minisatellite. (There are three GATA-1 binding sites in LL-genotype, while only two such sites in SS-genotype.)
